PharmaBoardroom

Maurice-Pierre Planel – President, CEPS, France

Maurice-Pierre Planel, president of the CEPS (Comité économique des produits de santé), details how the French government is unique in the way that…

Maria Fernanda Prado – Managing Director, Janssen Turkey

Maria Fernanda Prado, managing director of Janssen Turkey, elaborates on the unique dynamics at play in Turkey; an important emerging market. Prado…

Spain’s Top Three Regional Healthcare Systems

One of the unique aspects of the system is the fragmentation linked to the country's 17 autonomous regions The Spanish healthcare system performance…

The Changing Role of the Medical Rep

With more than 25 years pharmaceutical industry experience, Ian Chamberlain provides training to help pharma salespeople talk to customers and…

Sanofi growth returns thanks to Dupixent and revitalised vaccine…

Oliver Brandicourt, Sanofi’s CEO has kept his promise to steer the company back on the path to growth. This change in fortune comes after the French…

Top Pharma Producing Countries in Europe (2016)

The latest EFPIA data ranking European countries by the value of their pharmaceutical production. Switzerland is far and away the leader by this…

Korea: Hanmi Gets FDA Orphan Drug Approval for Leukaemia…

Korean Pharma company, Hanmi has won orphan drug status this week from the US Food and Drug Administration (FDA) for HM43239, a drug for the treatment…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences industry are busy preparing for…

Top Pharma Companies in Spain Ranking 2018

With Spain's economy on the road to recovery after experiencing a period of financial crisis, multinational companies are once again seeing the…

New Special Report on Pharma in Cyprus

With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare…

Philipp Haas – Chairman & CEO, DEVA, Turkey

Philipp Haas, chairman and CEO of DEVA, discusses the company’s export strategy and current positioning in the international pharmaceutical playing…

Bernardo Kanahuati – CEO, Bayer Spain

Following Bayer’s acquisition of Monsanto, a US agriculture giant, the company is facing a new era in which its pharmaceutical arm is still a highly…

Tagged with